Vanguard Group Inc. Has $598.16 Million Stock Holdings in Doximity, Inc. (NASDAQ:DOCS)

Vanguard Group Inc. increased its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 4.5% during the fourth quarter, Holdings Channel reports. The institutional investor owned 11,203,569 shares of the company’s stock after purchasing an additional 485,102 shares during the period. Vanguard Group Inc. owned about 0.06% of Doximity worth $598,159,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. LPL Financial LLC raised its position in shares of Doximity by 5.5% during the fourth quarter. LPL Financial LLC now owns 75,757 shares of the company’s stock worth $4,045,000 after purchasing an additional 3,967 shares during the period. Optimum Investment Advisors bought a new stake in Doximity during the 4th quarter valued at $43,000. KLP Kapitalforvaltning AS acquired a new position in Doximity during the fourth quarter worth $2,258,000. AXQ Capital LP bought a new position in shares of Doximity in the fourth quarter valued at $863,000. Finally, Sei Investments Co. grew its holdings in shares of Doximity by 72.8% during the fourth quarter. Sei Investments Co. now owns 274,011 shares of the company’s stock valued at $14,629,000 after buying an additional 115,403 shares during the last quarter. Institutional investors own 87.19% of the company’s stock.

Insider Activity at Doximity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the business’s stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the sale, the director now directly owns 6,360 shares in the company, valued at $366,463.20. The trade was a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 37.40% of the stock is owned by company insiders.

Analyst Ratings Changes

DOCS has been the topic of a number of analyst reports. Bank of America upped their target price on shares of Doximity from $54.00 to $57.00 and gave the stock a “neutral” rating in a report on Monday, January 6th. Leerink Partnrs raised Doximity from a “hold” rating to a “strong-buy” rating in a research note on Friday, February 7th. Leerink Partners upgraded Doximity from a “market perform” rating to an “outperform” rating and raised their target price for the company from $60.00 to $90.00 in a report on Friday, February 7th. The Goldman Sachs Group upped their price target on Doximity from $58.00 to $80.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. Finally, Mizuho raised their price objective on Doximity from $55.00 to $65.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Eleven equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $64.22.

Doximity Stock Down 0.7 %

Doximity stock opened at $58.11 on Tuesday. The firm has a 50 day moving average price of $65.57 and a 200-day moving average price of $54.69. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $85.21. The company has a market capitalization of $10.85 billion, a P/E ratio of 58.11, a P/E/G ratio of 4.10 and a beta of 1.34.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.